Cargando…

TCTN2: a novel tumor marker with oncogenic properties

Tectonic family member 2 (TCTN2) encodes a transmembrane protein that belongs to the tectonic family, which is involved in ciliary functions. Previous studies have demonstrated the role of tectonics in regulating a variety of signaling pathways at the transition zone of cilia. However, the role of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cano-Rodriguez, David, Campagnoli, Susanna, Grandi, Alberto, Parri, Matteo, Camilli, Elisa De, Song, Chaojun, Jin, Boquan, Lacombe, Aurelien, Pierleoni, Andrea, Bombaci, Mauro, Cordiglieri, Chiara, Ruiters, Marcel HJ, Viale, Giuseppe, Terracciano, Luigi, Sarmientos, Paolo, Abrignani, Sergio, Grandi, Guido, Pileri, Piero, Rots, Marianne G., Grifantini, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707019/
https://www.ncbi.nlm.nih.gov/pubmed/29221125
http://dx.doi.org/10.18632/oncotarget.20438
_version_ 1783282337351467008
author Cano-Rodriguez, David
Campagnoli, Susanna
Grandi, Alberto
Parri, Matteo
Camilli, Elisa De
Song, Chaojun
Jin, Boquan
Lacombe, Aurelien
Pierleoni, Andrea
Bombaci, Mauro
Cordiglieri, Chiara
Ruiters, Marcel HJ
Viale, Giuseppe
Terracciano, Luigi
Sarmientos, Paolo
Abrignani, Sergio
Grandi, Guido
Pileri, Piero
Rots, Marianne G.
Grifantini, Renata
author_facet Cano-Rodriguez, David
Campagnoli, Susanna
Grandi, Alberto
Parri, Matteo
Camilli, Elisa De
Song, Chaojun
Jin, Boquan
Lacombe, Aurelien
Pierleoni, Andrea
Bombaci, Mauro
Cordiglieri, Chiara
Ruiters, Marcel HJ
Viale, Giuseppe
Terracciano, Luigi
Sarmientos, Paolo
Abrignani, Sergio
Grandi, Guido
Pileri, Piero
Rots, Marianne G.
Grifantini, Renata
author_sort Cano-Rodriguez, David
collection PubMed
description Tectonic family member 2 (TCTN2) encodes a transmembrane protein that belongs to the tectonic family, which is involved in ciliary functions. Previous studies have demonstrated the role of tectonics in regulating a variety of signaling pathways at the transition zone of cilia. However, the role of tectonics in cancer is still unclear. Here we identify that TCTN2 is overexpressed in colorectal, lung and ovary cancers. We show that different cancer cell lines express the protein that localizes at the plasma membrane, facing the intracellular milieu. TCTN2 over-expression in cancer cells resulted in an increased ability to form colonies in an anchorage independent way. On the other hand, downregulation of TCTN2 using targeted epigenetic editing in cancer cells significantly reduced colony formation, cell invasiveness, increased apoptosis and impaired assembly of primary cilia. Taken together, our results indicate that TCTN2 acts as an oncogene, making it an interesting cancer-associated protein and a potential candidate for therapeutic applications.
format Online
Article
Text
id pubmed-5707019
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57070192017-12-07 TCTN2: a novel tumor marker with oncogenic properties Cano-Rodriguez, David Campagnoli, Susanna Grandi, Alberto Parri, Matteo Camilli, Elisa De Song, Chaojun Jin, Boquan Lacombe, Aurelien Pierleoni, Andrea Bombaci, Mauro Cordiglieri, Chiara Ruiters, Marcel HJ Viale, Giuseppe Terracciano, Luigi Sarmientos, Paolo Abrignani, Sergio Grandi, Guido Pileri, Piero Rots, Marianne G. Grifantini, Renata Oncotarget Research Paper Tectonic family member 2 (TCTN2) encodes a transmembrane protein that belongs to the tectonic family, which is involved in ciliary functions. Previous studies have demonstrated the role of tectonics in regulating a variety of signaling pathways at the transition zone of cilia. However, the role of tectonics in cancer is still unclear. Here we identify that TCTN2 is overexpressed in colorectal, lung and ovary cancers. We show that different cancer cell lines express the protein that localizes at the plasma membrane, facing the intracellular milieu. TCTN2 over-expression in cancer cells resulted in an increased ability to form colonies in an anchorage independent way. On the other hand, downregulation of TCTN2 using targeted epigenetic editing in cancer cells significantly reduced colony formation, cell invasiveness, increased apoptosis and impaired assembly of primary cilia. Taken together, our results indicate that TCTN2 acts as an oncogene, making it an interesting cancer-associated protein and a potential candidate for therapeutic applications. Impact Journals LLC 2017-08-24 /pmc/articles/PMC5707019/ /pubmed/29221125 http://dx.doi.org/10.18632/oncotarget.20438 Text en Copyright: © 2017 Cano-Rodriguez et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Cano-Rodriguez, David
Campagnoli, Susanna
Grandi, Alberto
Parri, Matteo
Camilli, Elisa De
Song, Chaojun
Jin, Boquan
Lacombe, Aurelien
Pierleoni, Andrea
Bombaci, Mauro
Cordiglieri, Chiara
Ruiters, Marcel HJ
Viale, Giuseppe
Terracciano, Luigi
Sarmientos, Paolo
Abrignani, Sergio
Grandi, Guido
Pileri, Piero
Rots, Marianne G.
Grifantini, Renata
TCTN2: a novel tumor marker with oncogenic properties
title TCTN2: a novel tumor marker with oncogenic properties
title_full TCTN2: a novel tumor marker with oncogenic properties
title_fullStr TCTN2: a novel tumor marker with oncogenic properties
title_full_unstemmed TCTN2: a novel tumor marker with oncogenic properties
title_short TCTN2: a novel tumor marker with oncogenic properties
title_sort tctn2: a novel tumor marker with oncogenic properties
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707019/
https://www.ncbi.nlm.nih.gov/pubmed/29221125
http://dx.doi.org/10.18632/oncotarget.20438
work_keys_str_mv AT canorodriguezdavid tctn2anoveltumormarkerwithoncogenicproperties
AT campagnolisusanna tctn2anoveltumormarkerwithoncogenicproperties
AT grandialberto tctn2anoveltumormarkerwithoncogenicproperties
AT parrimatteo tctn2anoveltumormarkerwithoncogenicproperties
AT camillielisade tctn2anoveltumormarkerwithoncogenicproperties
AT songchaojun tctn2anoveltumormarkerwithoncogenicproperties
AT jinboquan tctn2anoveltumormarkerwithoncogenicproperties
AT lacombeaurelien tctn2anoveltumormarkerwithoncogenicproperties
AT pierleoniandrea tctn2anoveltumormarkerwithoncogenicproperties
AT bombacimauro tctn2anoveltumormarkerwithoncogenicproperties
AT cordiglierichiara tctn2anoveltumormarkerwithoncogenicproperties
AT ruitersmarcelhj tctn2anoveltumormarkerwithoncogenicproperties
AT vialegiuseppe tctn2anoveltumormarkerwithoncogenicproperties
AT terraccianoluigi tctn2anoveltumormarkerwithoncogenicproperties
AT sarmientospaolo tctn2anoveltumormarkerwithoncogenicproperties
AT abrignanisergio tctn2anoveltumormarkerwithoncogenicproperties
AT grandiguido tctn2anoveltumormarkerwithoncogenicproperties
AT pileripiero tctn2anoveltumormarkerwithoncogenicproperties
AT rotsmarianneg tctn2anoveltumormarkerwithoncogenicproperties
AT grifantinirenata tctn2anoveltumormarkerwithoncogenicproperties